Home
About
Overview
Sharing Data
ORCID
Help
History (19)
A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events.
Oral ondansetron: a useful addition to the supportive care armamentarium?
See All 19 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral ondansetron: a useful addition to the supportive care armamentarium?
Hesketh PJ. Oral ondansetron: a useful addition to the supportive care armamentarium? Am J Clin Oncol. 1994 Apr; 17(2):147-9.
View in:
PubMed
subject areas
Administration, Oral
Antiemetics
Antineoplastic Combined Chemotherapy Protocols
Drug Administration Schedule
Humans
Nausea
Neoplasms
Ondansetron
Research Design
Treatment Outcome
Vomiting
authors with profiles
Paul Joseph Hesketh MD